Protagonist
is a California-based biopharmaceutical company that develops and commercializes peptide therapeutics for the treatment of gastrointestinal diseases... Read moreProtagonist
is a California-based biopharmaceutical company that develops and commercializes peptide therapeutics for the treatment of gastrointestinal diseases... Read more
News
Apr 23, 2025
FinanzNachrichten
Protagonist: Protagonist Therapeutics Announces Plenary Presentation on VERIFY Phase 3 Study with Rusfertide at ASCO 2025
Apr 16, 2025
Yahoo
Protagonist: Protagonist Therapeutics Reports Granting of Inducement Award
Apr 11, 2025
Medthority
Protagonist: Icotrokinra Phase III Psoriasis Data
Apr 10, 2025
FinanzNachrichten
Protagonist: Protagonist Therapeutics: Icotrokinra Results Show 75% of Adolescents with Plaque Psoriasis Achieved Completely Clear Skin and Demonstrate Favorable Safety Profile with a Once Daily Pill
Mar 18, 2025
FinanzNachrichten
Protagonist: Protagonist Therapeutics Named to Fast Company's Annual List of the World's Most Innovative Companies of 2025
Mar 12, 2025
BioCentury
Protagonist: Oral peptide win for Protagonist/J&J, Beam's base editor POC, and more: Clinical Report
Mar 12, 2025
Zacks
Protagonist: Protagonist Therapeutics (PTGX) Upgraded to Buy: Here's Why
Mar 11, 2025
Zacks
Protagonist: PTGX Up as J&J-Partnered Drug Meets Goal in Ulcerative Colitis Study
Mar 10, 2025
Endpoints News
Protagonist: J&J, Protagonist outline first IBD win for potential immunological blockbuster
Mar 10, 2025
Yahoo
Protagonist: Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out
Protagonist Competitors
1
2
3
4
5
6
7
8
9
10